Mumbai, June 2 -- Relisys Medical Devices is in early-stage discussions with global private equity firms KKR and TPG for a potential Rs.1,200-1,300 crore investment, with the transaction likely to offer a full or partial exit to existing investor Siguler Guff, two people familiar with the matter told Mint.

"While TPG is evaluating the company to strengthen its portfolio, KKR is in discussions with the medical devices maker to build out its med-tech platform under which it acquired Healthium Medtech last year from Apax Funds," one of the people cited above said. TPG, too, may look at developing a med-tech platform of its own, the person added.

A majority of the proceeds from the transaction, if it materialises, will likely be secondary i...